GlobeNewswire by notified

Dom Marchant, Chief Creative Officer, joins the executive leadership team at OPEN Health with a new vision to drive the creative communications practice

Share

UK, Oct. 23, 2023 (GLOBE NEWSWIRE) -- October 23rd, London, UK

Dom Marchant, Chief Creative Officer, joins the executive leadership team at OPEN Health with a new vision to drive the creative communications practice

Dom will be responsible for leading the company's overall creative strategy, with a specific focus on the creative communications practice, which specializes in data-driven creativity. By joining the OPEN Health executive leadership team, he will share this world-class, innovative approach throughout all of OPEN Health’s global practices, including scientific communications, patient engagement, and HEOR and market access.

“Data-driven creativity is central to all our services, and Dom demonstrates an innate vision for driving it within OPEN Health. He embodies a unique perspective and a freshness, seamlessly blending digital-first thinking with creative vision, but always with a commercial focus,” said Rob Barker, OPEN Health Group CEO.

Dom joined OPEN Health in 2021 through the acquisition of London-based creative agency ARK. He has a strong reputation in the industry, with a history of building successful healthcare agencies. In addition to 15 years’ experience in healthcare, he has worked with a diverse range of clients, including The Coca-Cola Company, Panasonic, Björk, and Ted Baker. His healthcare clients have included AZ, GSK, Alexion, BI, Takeda, Pfizer, and LEO.

With over 100 awards as Executive Creative Director, including two Cannes Lions, two Creative Floors, and most awarded agency at the PM Society Digital Awards in 2022 and 2023, he currently sits on the Interactive Media Council Inc. and the PM Society committee.

“We have built a solid reputation as a creative force over the past two years,” said Dom, “and we need to continue on that path, with more awards and more recognition for the highly creative and measurable work that typifies the data-driven approach.”

Dom begins in his role immediately.

About OPEN Health

OPEN Health unites deep scientific knowledge with wide-ranging specialist expertise to unlock possibilities that improve health outcomes and patient well-being. Working in partnership with our clients, we embrace our different perspectives and strengths to deliver fresh thinking and solutions that make a difference. OPEN Health is a flexible global organization that solves complex healthcare challenges across HEOR and market access, medical communications and creative omnichannel campaigns. For more information on OPEN Health, visit www.openhealthgroup.com.

Press contacts:
OPEN Health
Candice Subero, VP Global Marketing
candicesubero@openhealthgroup.com

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Resultat af aktietilbagekøb1.12.2023 17:41:01 CET | pressemeddelelse

Selskabet meddelte i selskabsmeddelelse 30/2023, at man havde besluttet at iværksætte et aktietilbagekøb på køb af optil 1.000.000 aktier til kurs 2.50 svarende til maksimalt DKK 2.5 mio. i perioden 22. november – 1. december 2023, begge dage inklusive. I hele perioden har der været indlagt en synlig stående budordrer i kurs 2.50, så markedet løbende har kunne følge tilbagekøbets udvikling, og som det også fremgik af selskabsmeddelelse 30/2023, så stod alle insidere tilbage for selskabets aktionærer, så insidere som ønskede at sælge aktier kun kunne tilbagesælge aktier den sidste dag, dvs. fra og med fredag d. 1. december 2023 kl. 09.00. Resultatet af insidernes evt. frasalg vil fremgå af en separat meddelelse. Resultatet af aktietilbagekøbsprogrammet blev at selskabet har tilbagekøbt 19.687 aktier til kurs 2.50 svarende til DKK 49.217,50. Selskabet ejer pr. dags dato totalt 4.854.063 egne aktier svarende til 9,06 % af selskabets aktiekapital. Det samlede antal aktier i virksomheden er

Registration of share capital increase in IDEX Biometrics 1 Dec 20231.12.2023 17:30:00 CET | Press release

Reference is made to the notice on 21 November 2023 regarding employees having exercised 389,608 incentive subscription rights at NOK 0.15 per share. The capital increase has been registered and the shares will be delivered soonest. Following the issue, the company's share capital is NOK 209,551,597.20 divided into 1,397,010,648 shares, each with a nominal value of NOK 0.15. For further information contact: Marianne Bøe, Investor Relations E-mail: marianne.boe@idexbiometrics.com Tel: +47 918 00186 About IDEX Biometrics IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As

Innofactor Plc: Share Repurchase 1.12.20231.12.2023 17:30:00 CET | Press release

Innofactor Plc Announcement 1.12.2023Innofactor Plc: Share Repurchase 1.12.2023In the Helsinki Stock ExchangeTrade date 1.12.2023Bourse trade BuyShare IFA1VAmount 4,600SharesAverage price/ share 1.1500EURTotal cost 5,290.00EURInnofactor Plc now holds a total of 561 829 sharesincluding the shares repurchased on 1.12.2023On behalf of Innofactor PlcNordea Bank OyjJanne Sarvikivi Sami HuttunenAdditional information:Sami Ensio, CEOInnofactor PlcTel. +358 50 584 2029sami.ensio@innofactor.comwww.innofactor.com Attachment IFA1V ENG 134

Wolters Kluwer named as a Leader in Gartner® Magic Quadrant™ for Financial Close and Consolidation Solutions1.12.2023 17:29:28 CET | Press release

PRESS RELEASE Wolters Kluwer named as a Leader in Gartner® Magic Quadrant™ for Financial Close and Consolidation Solutions Wolters Kluwer CCH Tagetik platform facilitates the end-to-end financial closing process, from account reconciliation and AI-based transaction matching to financial and management reporting and disclosure. NEW YORK – Dec. 1, 2023 – Wolters Kluwer, a global leader in professional information, software solutions and services, today announced that it has been recognized as a Leader in the 2023 Gartner Magic Quadrant for Financial Close and Consolidation Solutions, based on its completeness of vision and ability to execute. Last month, Wolters Kluwer was also recognized in the 2023 Gartner Market Guide for Financial Reconciliation Solutions. The CCH Tagetik Financial Close & Consolidation platform improves the speed and accuracy of all aspects of the financial close and consolidation process, ranging from account reconciliation and transaction matching to financial, ma

TGS Shareholders Approve the Merger Plan with PGS1.12.2023 17:09:37 CET | Press release

OSLO, Norway (1 December 2023) - Reference is made to the joint stock exchange announcement on 18 September 2023 by TGS ASA ("TGS" or the "Company," OSE: TGS) and PGS ASA ("PGS," OSE: PGS) regarding the combination of the two companies (the "Merger") to establish the premier energy data company, as well as subsequent announcements on 25 and 30 October 2023 regarding, respectively, the execution of the definitive merger agreement and notices for extraordinary general meetings for approval. An extraordinary general meeting in TGS was held today at 16:00 hours (Oslo time) as a virtual meeting. All proposals on the agenda were approved with requisite majorities, including the merger plan dated 25 October 2023 and the corresponding share capital increase in the Company. As separately announced by PGS earlier today, the merger has also been approved by the extraordinary general meeting in PGS. As a consequence, the decision to approve the merger will now be filed with the Norwegian Register